StocksBeiGene LtdBGNE

BGNE

BeiGene Ltd

233.47 -15.38 (-6.18%)
Giá Trì hoãn của NASDAQ, bằng USD Thị trường đóng cửa
Giao dịch
S
232.84
B
233.69
Hàng đầu
VolatilityAlerts
Free fall: $BGNE (BeiGene Ltd) plummets 7.6%Dịch
BGNE
BeiGene Ltd
232.84
-15.38 (-6.18%)
Giao dịch
DeepNews
$BGNE (BeiGene Ltd) BeiGene reports positive findings from Phase 3 trial of tislelizumab + chemotherapy in gastric cancer BeiGene (BGNE) announces positive findings from the Phase 3 RATIONALE 305 trial of tislelizumab versus placebo in combination with chemotherapy as a first-line treatment for seekingalpha.com/news/3790546-beigene-reports-positive-findings-from-phase-3-trial-of-tislelizumab-chemotherapy-in-gastric-cancer Dịch
DeepNews
$BGNE (BeiGene Ltd) BeiGene Ltd.’s Increase Of 0.03% Makes It Worthwhile To Consider Again BeiGene Ltd. (NASDAQ:BGNE) price on Friday, January 21, rose 0.03% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $251.45. A look at the stock’s price movement,... Xem thêm Dịch
VolatilityAlerts
$BGNE (BeiGene Ltd) share gains as it rises over 6.8%Dịch
BGNE
BeiGene Ltd
232.84
-15.38 (-6.18%)
Giao dịch
Thích Bình luậnChia sẻ
null
.
DeepNews
$BGNE (BeiGene Ltd) BeiGene receives approval of supplemental new drug application for BRUKINSA in China BeiGene (BGNE) announced that the Center for Drug Evaluation of the China National Medical Products Administration ((NMPA)) has accepted a supplemental new drug application seekingalpha.com/news/3789503-beigene-receives-approval-of-supplemental-new-drug-application-for-brukinsa-in-china Dịch